FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy

[cafead]

via

• Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
• Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the currently available oral solution
• New tablet formulation may provide greater freedom and independence for people with SMA thanks to simplified dose administration

article source